The Effect of Exenatide on Cardiovascular Risk Markers in Women With Polycystic Ovary Syndrome

Background: Polycystic ovary syndrome (PCOS) is associated with an adverse cardiovascular risk profile including a prothrombotic state. Exenatide has been shown to be effective at improving insulin sensitivity and weight loss in PCOS; therefore this study was undertaken to assess its effects on weig...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Endocrinol (Lausanne)
Autors principals: Dawson, Alison J., Sathyapalan, Thozhukat, Vince, Rebecca, Coady, Anne-Marie, Ajjan, Ramzi A., Kilpatrick, Eric S., Atkin, Stephen L.
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2019
Matèries:
Endocrinology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6454834/
https://ncbi.nlm.nih.gov/pubmed/31001199
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2019.00189
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars